Fundz

Veranex Acquires Devicia And Clarvin, Expanding Regulatory, Quality, And Clinical Expertise For Ivd And Medical Devices

PRIVATEOct 11, 2022

Acquiring Company

Veranex

Acquired Company

Devicia

RaleighSoftwareBiotechnologyHealth CareMedicalMedical DeviceConsultingManufacturingBiotechnologyQuality Assurance

Description

Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry, announced today that it has acquired an ecosystem of full-service medical device consultancy companies, providing regulatory and clinical affairs, quality assurance, and biocompatibility services for medical devices and in vitro diagnostic (IVD) devices. Based in Sweden, this ecosystem includes Devicia, a full-service partner offering clinical expertise; Clarvin, a provider of strategic guidance in regulatory affairs and quality assurance; and affiliate companies Kickfile, Lea Reg, and Limulus Bio. Together with the recent acquisition of Swiss-based Medidee, these companies further expand Veranex’s European reach and build regulatory, clinical, and quality service segments. This specifically strengthens Veranex’s medical device regulation (MDR) and in vitro diagnostic regulation (IVDR) strategy, adding expertise in biological evaluations and medical device software and expanding infrastructure and designating local representation in the European Union and United Kingdom.

Quick answer

Veranex is acquiring Devicia and Clarvin, announced October 11, 2022. Veranex is based in Raleigh, North Carolina, United States.

How much did Veranex pay for Devicia?
The deal value was not disclosed.
What does Veranex do?
Veranex is the world's first global Innovation Contract Research Organization (iCRO) providing integrated product development and contract research services for medical device and in-vitro diagnostic companies.
Where are Veranex and Devicia based?
Veranex is based in Raleigh, North Carolina, United States.
Who are the decision-makers at Veranex?
Fundz holds 3 contacts at Veranex. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Medical and Medical Device

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Veranex, and when

When Veranex changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Veranex raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Veranex, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Veranex. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Veranex

Location

Raleigh, North Carolina, United States

About

Veranex is the world's first global Innovation Contract Research Organization (iCRO) providing integrated product development and contract research services for medical device and in-vitro diagnostic companies. Founded in 2021 but with a legacy over 20 years, Veranex combines design engineering, preclinical research, clinical trials, regulatory affairs, quality consulting, manufacturing, and market access services under one roof. This integrated approach eliminates traditional handoffs between development phases, reducing timelines and budget variance for clients. The company serves medical device innovators from early-stage startups to global strategics across cardiovascular, neurovascular, ophthalmology, and diagnostic markets. With more than 800 specialists across North America, Europe, and Asia-Pacific, Veranex has supported over 1,000 device programs and 2,500 clinical trials (preclinical-feasibility and pivotal).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Veranex makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Suman
Senior decision-maker at this company
••••••••@••••••••

See Suman's verified email →

Jose
Senior decision-maker at this company
••••••••@••••••••

See Jose's verified email →

Andrea
Senior decision-maker at this company
••••••••@••••••••

See Andrea's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Veranex's next move

Learn about Strategic plan

Frequently asked

Who acquired Devicia?

Devicia was acquired by Veranex, based in Raleigh. The deal was reported on October 11, 2022. Veranex is the world's first global Innovation Contract Research Organization (iCRO) providing integrated product development and contract research services for medical device and in-vitro diagnostic companies. Veranex is privately held and operates in Software.

When did Veranex acquire Devicia?

Veranex's acquisition of Devicia was reported on October 11, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Devicia do?

Devicia is a full-service consulting firm offering clinical expertise for medical devices, supporting clients throughout the life cycle of medical device and IVD. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.